课题基金 / 基金详情

Chemokine Network and HIV Pathogenesis: New Insights into the Functional Heterogeneity of Monocyte-Derived Dendritic Cells and CD4+ T-Cells

Chemokine Network and HIV Pathogenesis: New Insights into the Functional Heterogeneity of Monocyte-Derived Dendritic Cells and CD4+ T-Cells
趋化因子网络和 HIV 发病机制：对单核细胞衍生的树突状细胞和 CD4 T 细胞功能异质性的新见解
批准号：
199383
负责人：
Ancuta Petronela
金额：
$7.29万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-09-01 至 2010-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=199383&lang=en
关键词：
Chemokines/Chemokine Receptors And Inflammation Dendritic Cells And Cd4+ T Cells Facs Sorting And Confocal Microscopy Hiv And Viral Reservoirs Immune And Virological Synapse Real Time Pcr And High Throughput Chemokine Screening

项目摘要

项目成果

Ancuta Petronela的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our hypothesis is that discrete uncharacterized subsets of monocyte-derived dendritic cells (MDDC) and CD4+ T-cells differentially contribute to anti-HIV immunity and viral replication/persistence and that specific chemokines and chemokine receptors gover
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Finding the Perfect Time to Hunt for HIV: A Tale of 36 Hours at the CHUM
Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy